Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
428.00
Change Change %
-4.70 -1.09%

Updated:06 Jul, 2020, 15:54 PM IST

BSE
428.10
Change Change %
-4.50 -1.04%

Updated:06 Jul, 2020, 16:01 PM IST

Glenmark Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Net Profit Before Taxes 1,218.83 2,552.90 -52.26%
Adjustments for Expenses & Provisions 133.67 507.42 -73.66%
Adjustments for Liabilities & Assets 63.29 -1,536.09 104.12%
Cash Flow from operating activities 1,123.72 877.72 28.03%
Cash Flow from investing activities -1,137.12 -2,580.29 55.93%
Cash Flow from financing activities -61.58 1,879.38 -103.28%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents -74.98 176.81 -142.41%
Opening Cash & Cash Equivalents 250.88 74.24 237.92%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations 0.15 -0.17 186.31%
Closing Cash & Cash Equivalent 176.05 250.88 -29.83%
Top
Listen to the latest songs, only on JioSaavn.com